Braftovi (encorafenib) belongs to a class of kinase inhibitors used in treating Melanoma, Colorectal Cancer (CRC), and NSCLC. Patients often ask, “Is Braftovi available in India for purchase?” Unfortunately, Braftovi has not yet been approved by Indian regulatory authorities, so it cannot be bought from local chemists or hospitals. However, Indian Pharma Network (IPN) provides a solution by facilitating its legal import through the Named Patient Program. This ensures that patients who urgently need Braftovi can still access it from global sources where it is already approved. With proper medical documentation and compliance procedures, IPN ensures patients receive genuine medicines safely. For patients in India seeking advanced treatment options like Braftovi, IPN is a trusted partner in making it possible. Kindly contact us today via Call/WhatsApp: +91-9310090915 to learn more.